Skip to main content

GLOBE LIFE INC.

For the period ended Dec 31, 2025. Filed Feb 25, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Feb 25, 2026

GL$161.83+3.0%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Restrictions Note 13—Shareholders' Equity

Restrictions: Restrictions exist on the flow of funds to Globe Life Inc. from its insurance subsidiaries. Statutory regulations require life insurance subsidiaries to maintain certain minimum amounts of capital and surplus. Dividends from insurance subsidiaries of Globe Life Inc. are restricted based on regulations by their states of domicile. Additionally, insurance company distributions are generally not permitted in excess of statutory surplus. Subsidiaries are also subject to certain minimum capital requirements. Subsidiaries of Globe Life paid cash dividends to the Parent Company in the amount of $816 million in 2025, $693 million in 2024, and $460 million in 2023. As of December 31, 2025, dividends from our U.S. insurance subsidiaries to the Parent Company available to be paid in 2026 are limited to the amount of $211 million without regulatory approval, such that $1.4 billion was considered restricted net assets of the subsidiaries. Dividends exceeding these limitations may be available during the year pending regulatory approval. While there are no legal restrictions on the payment of dividends to shareholders from Globe Life's retained earnings, retained earnings as of December 31, 2025 were restricted by lenders’ covenants which require the Company to maintain and not distribute $5.6 billion from its total consolidated retained earnings of $8.5 billion.

Earnings per Share: A reconciliation of basic and diluted weighted-average shares outstanding used in the computation of basic and diluted earnings per share is as follows:

Year Ended December 31,
202520242023
Basic weighted average shares outstanding81,376,84589,278,57495,098,474
Weighted average dilutive options outstanding1,148,147382,8481,265,367
Diluted weighted average shares outstanding82,524,99289,661,42296,363,841
Antidilutive shares—2,140,787422,739

Antidilutive shares are excluded from the calculation of diluted earnings per share. All antidilutive shares noted above result from outstanding out of the money employee and Director stock options.

Note 14—Stock-Based Compensation

Globe Life's stock-based compensation consists of stock options, restricted stock, restricted stock units, and performance shares. Certain employees and members of the board of directors (directors) have been granted fixed equity options to buy shares of Globe Life Inc. stock at the market value of the stock on the date of grant, under the provisions of the Globe Life stock option plans. The options are exercisable during the period commencing from the date they vest until expiring according to the terms of the grant. Options generally expire the earlier of employee termination or option contract term, which are either seven-year orten-year terms. However, depending on the circumstances of termination, options may be exercised for a period of time following termination of employment or upon death or disability. Options generally vest in accordance with the following schedule:

Shares vested by period
Contract Period6 MonthsYear 1Year 2Year 3
Directors7 years100%—%—%—%
Employees7 years—%—%50%50%

All employee options vest immediately upon retirement on or after the attainment of age 65, upon death, or disability. Globe Life generally issues shares for the exercise of stock options from treasury stock. The Company generally uses the proceeds from option exercises to buy shares of Globe Life common stock in the open market to reduce the dilution from option exercises.

A summary of stock compensation activity for each of the three years ended December 31, 2025 is presented below:

202520242023
Stock-based compensation expense recognized(1)$53,355$40,118$30,736
Tax benefit recognized10,8297,08511,178

(1)No stock-based compensation expense was capitalized in any period in accordance with applicable GAAP.

Additional stock compensation information is as follows at December 31:

20252024
Unrecognized compensation(1)$49,461$46,956
Weighted average period of expected recognition (in years)(1)0.640.53

(1)Includes stock options, restricted stock units and performance shares.

No equity awards were cash settled during the three years ended December 31, 2025.

Options: The following table summarizes information about stock options outstanding at December 31, 2025.

Options Outstanding · Options Exercisable
Range ofExercise PricesNumberOutstandingWeighted-AverageRemainingContractualLife (Years)Weighted-AverageExercisePriceNumberExercisableWeighted-AverageExercisePrice
$50.64 - $98.321,283,9181.89$92.511,283,918$92.51
100.74745,0001.15100.74745,000100.74
103.23935,4903.14103.23935,490103.23
105.56 - 128.401,339,5364.97124.90266,584118.92
$50.64 - $128.404,303,9442.99$106.343,230,992$99.69

An analysis of option activity for each of the three years ended December 31, 2025, is as follows:

202520242023
OptionsWeighted-AverageExercise PriceOptionsWeighted-AverageExercise PriceOptionsWeighted-AverageExercise Price
Outstanding—beginning of year5,825,957$99.745,940,320$96.196,962,374$91.73
Granted:
7-year term349,342127.43520,810128.32497,060120.49
Exercised(1,842,860)89.23(584,993)88.52(1,375,313)82.95
Expired and forfeited(28,495)120.48(50,180)106.62(143,801)90.92
Outstanding—end of year4,303,944$106.345,825,957$99.745,940,320$96.19
Exercisable at end of year3,230,992$99.694,376,436$93.734,003,028$91.23

Additional information about Globe Life's stock option activity as of December 31, 2025 and 2024 is as follows:

20252024
Outstanding options:
Weighted-average remaining contractual term (in years)2.993.15
Aggregate intrinsic value$144,251$81,703
Exercisable options:
Weighted-average remaining contractual term (in years)2.242.48
Aggregate intrinsic value$129,787$77,946

Selected stock option activity for the three years ended December 31, 2025, is presented below:

202520242023
Weighted-average grant-date fair value of options granted (per share)$39.92$33.80$32.25
Intrinsic value of options exercised73,97017,12749,163
Cash received from options exercised164,44851,786114,080
Actual tax benefit received8,1012,4899,379

Additional information concerning Globe Life's unvested options is as follows at December 31:

20252024
Number of shares outstanding1,072,9521,449,521
Weighted-average exercise price (per share)$126.38$117.88
Weighted-average remaining contractual term (in years)5.255.19
Aggregate intrinsic value$14,464$3,757

Globe Life expects that substantially all unvested options will vest.

Restricted Stock: Restricted stock grants consist of time-vested grants, restricted stock units, and performance shares. Time-vested restricted stock is available to directors and vests oversix months. The directors' restricted stock units vest oversix months and are converted to shares upon their retirement from the Board. Employees' restricted stock units vest and become non-forfeitable on the vesting date (generally three years from the grant date) or upon meeting certain retirement criteria, or in the event of death or disability. Director restricted stock and restricted stock units are generally granted on the first business day of the calendar year. Performance shares are granted to a limited number of senior executives. Performance shares have athree-year performance period and are not settled in shares until the certification of the achievement of the performance objectives forthree-year performance period. While the grant specifies a stated target number of shares, the determination of the actual settlement in shares will be based on the achievement of certain performance objectives of Globe Life over thethree-year performance period. Certain executive restricted stock and performance share grants contain terms related to age that could accelerate vesting.

Following are the restricted stock units outstanding for each of the three years ended December 31, 2025:

Year of grantsOutstanding as of year end
2023163,108
2024219,864
2025(1)312,663

(1)Includes dividend equivalent units.

Below is the final determination of the performance share grants in 2021 to 2023:

Year of grantsFinal settlement of sharesFinal settlement date
2021143,211February 28, 2024
2022152,680February 26, 2025
2023149,755February 25, 2026

For the 2024 and 2025 performance share grants, actual shares that could be distributed range from 0 to 145 thousand for the 2024 grants and 0 to 297 thousand shares for the 2025 grants.

A summary of restricted stock grants for each of the years in the three-year period ended December 31, 2025, is presented in the table below:

2025(1)20242023
Directors restricted stock:
Shares6,5307,3757,110
Price per share$115.20$122.06$119.59
Aggregate value$752$900$850
Percent vested100%100%100%
Directors restricted stock units (including dividend equivalents):
Shares9,5824,8549,479
Price per share$114.84$120.16$117.73
Aggregate value$1,100$583$1,116
Percent vested100%100%100%
Employees restricted stock units:
Shares106,089101,01196,975
Price per share$127.43$127.29$120.18
Aggregate value$13,519$12,858$11,654
Percent vested—%—%—%
Performance shares:
Target shares148,68896,80081,300
Target price per share$127.44$128.40$120.49
Aggregate value$18,948$12,429$9,796
Percent vested—%—%—%

(1)Includes dividend equivalent units.

Time-vested restricted stockholders are entitled to dividend payments on the unvested stock. Director restricted stock unit holders are entitled to dividend equivalents. These equivalents are granted in the form of additional restricted stock units and vest immediately upon grant. Dividend equivalents are applicable only to directors' restricted stock units and beginning in 2025 employee performance shares and restricted stock unit awards. Prior to 2025, the performance awards and restricted stock units held by employees were not entitled to dividend equivalents and not entitled to dividend payments until the shares vest and are settled.

An analysis of nonvested restricted stock is as follows:

ExecutivePerformanceSharesDirectorsRestrictedStockDirectorsRestrictedStockUnitsEmployeesRestrictedStockUnitsTotal
2023:
Balance at December 31, 2022398,535———398,535
Grants81,3007,1109,47996,975194,864
Additional performance shares(1)(28,857)———(28,857)
Restriction lapses(84,298)(7,110)(9,479)—(100,887)
Forfeitures(12,600)——(4,410)(17,010)
Balance at December 31, 2023354,080——92,565446,645
2024:
Grants96,8007,3754,854101,011210,040
Additional performance shares(1)84,712———84,712
Restriction lapses(143,211)(7,375)(4,854)(437)(155,877)
Forfeitures(6,000)——(10,008)(16,008)
Balance at December 31, 2024386,381——183,131569,512
2025:
Grants148,6886,5309,582106,089270,889
Additional performance shares(1)83,626———83,626
Restriction lapses(152,680)(6,530)(9,582)(2,473)(171,265)
Forfeitures———(20,399)(20,399)
Balance at December 31, 2025466,015——266,348732,363

(1)Estimated additional (reduced) share grants expected due to achievement of performance criteria.

An analysis of the weighted-average grant-date fair values per share of non-vested restricted stock is as follows for the year 2025:

Executive Performance SharesDirectors Restricted StockDirectors Restricted Stock UnitsEmployeesRestrictedStockUnits
Grant-date fair value per share at January 1, 2025$115.78$—$—$124.02
Grants127.44115.20114.34127.18
Estimated additional performance shares126.75———
Restriction lapses(103.23)(115.20)(114.34)(119.99)
Forfeitures———(125.89)
Grant-date fair value per share at December 31, 2025125.58——125.17

Note 15—Business Segments

Globe Life is organized into three operating segments: life, health, and investments.

Globe Life's reportable insurance segments are based on the insurance product lines it markets and administers: life insurance and supplemental health insurance. There is also an investment segment that manages the investment portfolio and cash flow for the insurance segments. The Company's chief operating decision makers (the "CODM"), our Co-CEOs, evaluate the overall performance of the operations of the Company in accordance with these segments.

Life insurance products marketed by Globe Life include traditional whole life and term life insurance. Health insurance products are generally guaranteed renewable and include Medicare Supplement, cancer, critical illness, accident, and other limited-benefit supplemental hospital and surgical products.

The following tables present segment premium revenue by each of Globe Life's distribution channels.

Premium Income by Distribution Channel

LifeHealthTotal
Distribution ChannelAmount% ofTotalAmount% ofTotalAmount% ofTotal
American Income$1,791,35653$124,9478$1,916,30339
Direct to Consumer981,0062976,51451,057,52021
Liberty National390,09412190,46812580,56212
United American6,188—666,75844672,94614
Family Heritage7,404—468,06331475,46710
Other187,4226——187,4224
Total premium$3,363,470100$1,526,750100$4,890,220100
LifeHealthTotal
Distribution ChannelAmount% ofTotalAmount% ofTotalAmount% ofTotal
American Income$1,698,20952$123,1239$1,821,33239
Direct to Consumer988,5223071,99351,060,51523
Liberty National371,06112190,38114561,44212
United American6,600—591,77442598,37413
Family Heritage6,661—427,65430434,3159
Other190,2946——190,2944
Total premium$3,261,347100$1,404,925100$4,666,272100
LifeHealthTotal
Distribution ChannelAmount% ofTotalAmount% ofTotalAmount% ofTotal
American Income$1,588,70251$120,3329$1,709,03438
Direct to Consumer991,4063268,57551,059,98124
Liberty National349,73611187,93414537,67012
United American7,311—545,72342553,03413
Family Heritage6,134—396,20930402,3439
Other193,9556——193,9554
Total premium$3,137,244100$1,318,773100$4,456,017100

Due to the nature of the life and health insurance industry, Globe Life has no individual or group which would be considered a major customer. Substantially all of Globe Life's business is conducted in the United States.

The measure of profitability established by the CODMs for the insurance segments is underwriting margin before other income and administrative expenses, in accordance with the manner in which the segments are managed. It essentially represents gross profit margin on insurance products before insurance administrative expenses and consists primarily of premium less net policy benefits, acquisition expenses, and commissions. Required interest on policy liabilities is reflected as a component of the Investment segment (rather than as a component of underwriting margin in the insurance segment) in order to match this cost with the investment income earned on the assets supporting the policy liabilities.

The measure of profitability for the Investment segment is excess investment income, representing the net income earned on the investment portfolio in excess of policy requirements. Other than the required interest on the insurance segments, no other intersegment revenues or expenses are recognized. Expenses directly attributable to corporate operations are included in the “Corporate & Other” category. Stock-based compensation expense is considered a corporate expense by Globe Life management and is included in this category. All other unallocated revenues and expenses on a pretax basis, including insurance administrative expense and interest on debt, are also included in the “Corporate & Other” segment category.

Globe Life holds a sizable investment portfolio to support its insurance liabilities, the yield from which is used to offset policy benefit, acquisition, administrative, and tax expenses. This yield or investment income is taken into account when establishing premium rates and profitability expectations for its insurance products. From time to time, investments are sold or called, or experience a credit loss event, each of which are reflected by the Company as realized gain (loss)—investments. These gains or losses generally occur as a result of disposition due to issuer calls, compliance with Company investment policies, or other reasons often beyond management’s control. Unlike investment income, realized gains and losses are incidental to insurance operations, and only overall yields are considered when setting premium rates or insurance product profitability expectations. While these gains and losses are not relevant to segment profitability or core operating results, they can have a material positive or negative result on net income. For these reasons, management removes realized investment gains and losses when it views its segment operations.

Management also removes non-operating items unrelated to the Company's core insurance activities when evaluating those results. Therefore, these items are excluded in its presentation of segment results because accounting guidance requires that operating segment results be presented as management views its business. All of these items are included in “Other operating expense” on the Consolidated Statements of Operations for the appropriate year. See additional detail below in the tables.

Year Ended December 31, 2025
Life · Health · Investment · Consolidated
Revenue:
Premium$3,363,470$1,526,750$—$4,890,220
Net investment income——1,130,1981,130,198
Segment revenue3,363,4701,526,7501,130,1986,020,418
Realized gains (losses)(27,788)
Other income1,688
Total consolidated revenue$5,994,318
Expenses:
Policy obligations(1)1,924,929931,14122,4152,878,485
Required interest on reserves(845,875)(113,832)969,3909,683
Amortization of acquisition costs386,45059,897—446,347
Commissions174,029173,490—347,519
Premium taxes68,13229,825—97,957
Non-deferred acquisition costs146,44456,101—202,545
Segment profit or (loss)$1,509,361$390,128$138,3932,037,882
Insurance administrative expenses:
Salaries137,015
Other employee costs41,609
Information technology costs82,573
Legal costs22,510
Other administrative costs71,888
Parent expense14,182
Stock-based compensation expense53,355
Interest expense141,221
Legal proceedings17,053
Other expenses2,183
Annuity(7,782)
Total expenses4,558,343
Income before income taxes per Consolidated Statement of Operations$1,435,975

(1)Policy obligations are based upon policyholder behavior and impacts related to lapses, mortality, and morbidity. For detailed information, including remeasurement gains and losses, see Note 6—Policy Liabilities.

Year Ended December 31, 2024
Life · Health · Investment · Consolidated
Revenue:
Premium$3,261,347$1,404,925$—$4,666,272
Net investment income——1,135,6311,135,631
Segment revenue3,261,3471,404,9251,135,6315,801,903
Realized gains (losses)(24,188)
Other income354
Total consolidated revenue$5,778,069
Expenses:
Policy obligations(1)2,000,977851,57720,969$2,873,523
Required interest on reserves(811,147)(110,342)950,25828,769
Amortization of acquisition costs356,22352,224—408,447
Commissions159,703158,869—318,572
Premium taxes68,36028,421—96,781
Non-deferred acquisition costs134,63451,753—186,387
Segment profit or (loss)$1,352,597$372,423$164,4041,889,424
Insurance administrative expenses:
Salaries129,369
Other employee costs36,176
Information technology costs80,555
Legal costs30,478
Other administrative costs65,852
Parent expense12,400
Stock-based compensation expense40,118
Interest expense127,092
Legal proceedings21,575
Other expenses2,620
Annuity(7,282)
Total expenses4,451,432
Income before income taxes per Consolidated Statement of Operations$1,326,637

(1)Policy obligations are based upon policyholder behavior and impacts related to lapses, mortality, and morbidity. For detailed information, including remeasurement gains and losses, see Note 6—Policy Liabilities.

Year Ended December 31, 2023
Life · Health · Investment · Consolidated
Revenue:
Premium$3,137,244$1,318,773$—$4,456,017
Net investment income——1,056,8841,056,884
Segment revenue3,137,2441,318,7731,056,8845,512,901
Realized gains (losses)(65,676)
Other income308
Total consolidated revenue$5,447,533
Expenses:
Policy obligations(1)2,050,789776,3629,061$2,836,212
Required interest on reserves(772,701)(106,516)917,44138,224
Amortization of acquisition costs327,42650,598—378,024
Commissions145,678150,192—295,870
Premium taxes64,57126,440—91,011
Non-deferred acquisition costs128,50943,760—172,269
Segment profit or (loss)$1,192,972$377,937$130,3821,701,291
Insurance administrative expenses:
Salaries119,699
Other employee costs35,905
Information technology costs64,998
Legal costs15,335
Other administrative costs65,224
Parent expense10,866
Stock-based compensation expense30,736
Interest expense102,316
Legal proceedings900
Other expenses4,170
Annuity(8,492)
Total expenses4,253,267
Income before income taxes per Consolidated Statement of Operations$1,194,266

(1)Policy obligations are based upon policyholder behavior and impacts related to lapses, mortality, and morbidity. For detailed information, including remeasurement gains and losses, see Note 6—Policy Liabilities.

Assets for each segment are reported based on a specific identification basis. The insurance segments’ assets contain DAC. The investment segment includes the investment portfolio, cash, and accrued investment income. Goodwill is assigned to the insurance segments at the time of purchase. All other assets are included in the annuity and other corporate category. The tables below reconcile segment assets to total assets as reported on the Consolidated Balance Sheets.

Assets by Segment

At December 31, 2025
Life · Health · Investment · Consolidated
Cash and invested assets$—$—$20,614,713$20,614,713
Accrued investment income——272,818272,818
Deferred acquisition costs6,147,750851,386—6,999,136
Goodwill309,609180,837—490,446
Total segment assets$6,457,359$1,032,223$20,887,53128,377,113
Annuity and other corporate2,436,579
Total assets$30,813,692
At December 31, 2024
Life · Health · Investment · Consolidated
Cash and invested assets$—$—$19,736,888$19,736,888
Accrued investment income——269,791269,791
Deferred acquisition costs5,700,755793,421—6,494,176
Goodwill309,609180,837—490,446
Total segment assets$6,010,364$974,258$20,006,67926,991,301
Annuity and other corporate2,084,880
Total assets$29,076,181

Liabilities for each segment are reported also on a specific identification basis similar to the assets. The insurance segments' liabilities contain future policy benefits, unearned and advance premiums, and policy claims and other benefits payable. Other policyholders' funds and annuities are included in annuity and other corporate as well as current and deferred income taxes payable. Debt represents both short and long-term. The tables below reconcile segment liabilities to total liabilities as reported on the Consolidated Balance Sheets.

Liabilities by Segment

At December 31, 2025
Life · Health · Investment · Consolidated
Future policy benefits$16,123,927$2,465,091$—$18,589,018
Unearned and advance premiums199,01171,652—270,663
Policy claims and other benefits payable315,595225,237—540,832
Debt——2,625,4492,625,449
Other95,047—437,000532,047
Total segment liabilities$16,733,580$2,761,980$3,062,44922,558,009
Annuity and other corporate2,281,104
Total liabilities$24,839,113
At December 31, 2024
Life · Health · Investment · Consolidated
Future policy benefits$15,484,596$2,316,094$—$17,800,690
Unearned and advance premiums198,12759,504—257,631
Policy claims and other benefits payable321,838210,994—532,832
Debt——2,739,6522,739,652
Other96,604—372,000468,604
Total segment liabilities$16,101,165$2,586,592$3,111,65221,799,409
Annuity and other corporate1,971,252
Total liabilities$23,770,661
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.